Kimberlee C. Drapkin, CFO and Treasurer at Jounce Therapeutics, Inc. (JNCE), sold 7,200 shares at $8.06 ($58K) on 2020-09-01, disclosed to the SEC on 2020-09-02.
Open-market sale of $58k JNCE by CFO and Treasurer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| JNCE | SELL | 2021-01-22 | $536K | — | Filing → |
| JNCE | SELL | 2021-01-11 | $40K | — | Filing → |
| JNCE | SELL | 2020-08-18 | $10K | — | Filing → |